AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Recordati Industria Chimica e Farmaceutica

AGM Information Apr 21, 2023

4056_rns_2023-04-21_aff0e13d-d359-44e0-95c0-9db8f57be9f6.pdf

AGM Information

Open in Viewer

Opens in native device viewer

Summary report of the votes

pursuant to article 125-quater, paragraph 2 of the Legislative Decree 24th February 1998 no. 58

Item 1.a of the agenda

Board of Directors' Review of Operations; Report of the Board of Statutory Auditors; Financial Statements as at and for the financial year ended 31st December 2022; related and consequent resolutions: Financial Statements as at 31st December 2022;

Shares no. % Shares represented in the % of the Share Capital
meeting
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
In favor 176,240,726 98.970% 84.275%
Against 708,387 0.398% 0.339%
Abstension 1,126,430 0.633% 0.539%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Item 1.b of the Agenda

Board of Directors' Review of Operations; Report of the Board of Statutory Auditors; Financial Statements as at and for the financial year ended 31st December 2022; related and consequent resolutions: allocation of the profit for the 2022 financial year.

Shares no. % Shares represented in the % of the Share Capital
meeting
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
In favor 178,030,448 99.975% 85.131%
Against 34,288 0.019% 0.016%
Abstension 10,807 0.006% 0.005%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Item 2.a of the Agenda

Appointment of the Board of Statutory Auditors: appointment of the members of the Board of Statutory Auditors;

Shares no. % Shares represented in the
meeting
% of the Share Capital
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
Slate 1 118,517,527 66.555% 56.673%
Slate 2 59,064,313 33.168% 28.244%
Against 337,007 0.189% 0.161%
Abstension 106,249 0.060% 0.051%
Total 178,025,096 99.972% 85.128%
Not voting 50,447 0.028% 0.024%
Total 178,075,543 100.000% 85.153%

Item 2.b of the Agenda

Appointment of the Board of Statutory Auditors: appointment of the Chair of the Board of Statutory Auditors;

Please be informed that this item on the agenda was not put to the vote, as the office of Chair of the Board of Statutory Auditors, pursuant to Article 26 of the By-laws, is held by the first person listed in the second slate that obtained the highest number of votes at the Shareholders' Meeting after the first slate.

Item 2.c of the Agenda

Appointment of the Board of Statutory Auditors: determination of their remuneration.

Shares no. % Shares represented in the % of the Share Capital
meeting
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
In favor 177,344,543 99.590% 84.803%
Against 711,340 0.399% 0.340%
Abstension 19,660 0.011% 0.009%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Item 3.a of the Agenda

Report on the remuneration policy and the remuneration paid pursuant to article 123-ter, paragraphs 3-bis and 6, of Legislative Decree no. 58 of 24th February 1998: binding resolution on the first section regarding the remuneration policy;

Shares no. % Shares represented in the % of the Share Capital
meeting
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
In favor 162,238,987 91.107% 77.580%
Against 15,572,149 8.745% 7.446%
Abstension 264,407 0.148% 0.126%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Item 3.b of the Agenda

Report on the remuneration policy and the remuneration paid pursuant to article 123-ter, paragraphs 3-bis and 6, of Legislative Decree no. 58 of 24th February 1998: non-binding resolution on the second section on the remuneration paid for 2022.

Shares no. % Shares represented in the % of the Share Capital
meeting
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
In favor 135,594,135 76.144% 64.839%
Against 42,076,787 23.629% 20.120%
Abstension 404,621 0.227% 0.193%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Item 4 of the Agenda

Approval of the long-term incentive plan based on financial instruments named "2023-2025 Performance Shares Plan", upon withdrawal of the "2021-2023 Stock Option Plan" concerning the grant of stock options scheduled for 2023; related and consequent resolutions in accordance with article 114-bis of Legislative Decree no. 58 of 24th February 1998.

Shares no. % Shares represented in the % of the Share Capital
meeting
178,075,543 100% 85.153%
178,075,543 85.153%
0 0.000% 0.000%
100.000%
Shares no. % participants in the vote % of the Share Capital
In favor 139,133,235 78.132% 66.531%
Against 38,688,708 21.726% 18.500%
Abstension 253,600 0.142% 0.121%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Item 5 of the Agenda

Proposal to authorise the purchase and utilisation of treasury stock; related and consequent resolutions.

Shares no. % Shares represented in the % of the Share Capital
meeting
Quorum of the shareholders' meeting 178,075,543 100% 85.153%
Shares for which the Designated Representative
has instructions for the agenda to be voted
(voting quorum): 178,075,543 100.000% 85.153%
Shares for which the Designative Representative
had no instructions: 0 0.000% 0.000%
Shares no. % participants in the vote % of the Share Capital
In favor 177,857,304 99.877% 85.048%
Against 218,239 0.123% 0.104%
Abstension 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%
Not voting 0 0.000% 0.000%
Total 178,075,543 100.000% 85.153%

Talk to a Data Expert

Have a question? We'll get back to you promptly.